Effect of Ramosetron on Bowel Motility After Gynecological Surgery

• Status: Unknown status
• Trial end date: 2017-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

Ramosetron is effective in preventing postoperative nausea and vomiting. Several studies reported that ramosetron is also effective treatment of irritable bowel syndrome. The investigators examine the effect of ramosetron on postoperative bowel motility.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kyunghee University Medical Center
• Treatments: Ramosetron

Criteria

Inclusion Criteria:

• 20-70 yrs of age

• ASA(American Society of Anesthesiologists) physical status class I or II

• Scheduled for gynecological laparoscopic surgery

Exclusion Criteria:

• Allergic to study drugs

• Antiemetics or steroids use within 24 hrs prior to surgery

• Dependence upon opioids

• Insulin dependent Diabetes Mellitus

• Cardiovascular or pulmonary disease

• Renal or hepatic insufficiency

• BMI>=35kg/m2

• History of motion sickness or PONV

• Cigarette smoker

• Conversion to open laparotomy from laparoscopic surgery

• Pregnants